Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the HyperDetector Digital Solution Screening Assay for Rapid Screening for Potential SARS-CoV-2 (COVID-19) Infection

NCT05124496 is registered in ClinicalTrials.gov with HyperSpectral APD as lead sponsor.

NCT NCT05124496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the HyperDetector Digital Solution Screening Assay for Rapid Screening for Potential SARS-CoV-2 (COVID-19) Infection
Lead sponsor
HyperSpectral APD
Phase
Observational
Overall status
Suspended
Start date
December 11, 2020
Completion date
December 30, 2021
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 infection